Background. Crystal-storing histiocytosis (CSH) is a poorly described complication of monoclonal gammopathy featuring histiocyte lysosomal storage of κ light chain (κLC) crystals. Although CSH is usually associated with systemic manifestations, renal involvement is uncommon. Methods. To investigate the molecular mechanisms implicated in κLC crystallization, we performed immunopathological and molecular studies in three patients with CSH and renal Fanconi syndrome (CSH/FS). The Vκ sequences were determined, and resulting molecular models were compared with previously reported myeloma-associated FS κLC sequences. Results. All patients presented with chronic tubulo-interstitial nephritis and renal FS with accumulation of monoclonal κLC crystals within proximal tubular cells. They showed peri-renal and interstitial infiltration by histiocytes containing eosinophilic crystalline inclusions (pseudopseudo-Gaucher cells). LC sequences were determined and assigned to their germline counterparts, in strong homology with previously reported myeloma-associated FS sequences. Comparison of CSH/FS Vκ domain 3D structures with the germline-encoded structures and those from patients with myeloma-associated FS underlined distinct hydrophobic residues exposed to the solvent in two patients, likely favouring the formation of a variant form of crystals that may further resist degradation after phagocytosis. Conclusion. Although CSH/FS and myeloma-associated FS are closely related disorders, peculiar mutations in the V domains of CSH/FS monoclonal κLCs, different from those in myeloma-associated FS, may account for crystal morphology, predominant accumulation within histiocytes and multiple organ involvement in CSH.
Introduction
Monoclonal gammopathy may be associated with accumulation of immunoglobulin (Ig) crystals in various tissues. In crystalcryoglobulinaemia, crystals composed of an entire monoclonal Ig are found in extracellular fluids and within the cytoplasm of various cells [1, 2] . Myeloma-associated renal Fanconi syndrome (FS) is a rare disorder characterized by proximal tubule dysfunction related to reabsorption of a monoclonal Ig light chain (LC), almost invariably of the κ type [3] . The hallmark of Fanconi syndrome (FS) is the accumulation of monoclonal κ light chain (κLCs) crystalline inclusions within the endolysosomal compartment of proximal tubular cells. Most κLCs are from the VκI subgroup and derive from two germline genes, O2/O12 or O8/O18 [4, 5] . Unlike other monoclonal LCs degraded in tubular cell lysosomes, LCs from FS patients are often partly resistant to proteolysis [4, 6] . Peculiarities of the variable (V) κ domain, notably hydrophobic residues at position 30, account for resistance to proteolysis and promote self reactivity and crystallization. Crystal formation is sometimes lacking, as described for monoclonal Vκ III LCs encoded by the L2/ L16 or L6 genes [4, 7] .
Accumulation of immunoglobulinic crystals within lysosomes of histiocytes in the bone marrow or other organs defines crystal-storing histiocytosis (CSH). In CSH invariably associated with κLC monoclonal gammopathy, crystals are mostly made up of monoclonal κLCs and more rarely of Ig heavy chains [8] . As histiocytes featuring crys-tal inclusions in CSH mimic Gaucher cells in genetic lysosomal storage disorders or pseudo-Gaucher cells seen in chronic myeloid leukaemia, they are referred to as 'pseudo-pseudo-Gaucher cells' (PPGC) [9] . Renal manifestations have been rarely described in CSH [8] . Inclusionbearing histiocytes may infiltrate the renal interstitium, while lysosomal inclusions may be present within proximal tubular cells in patients with proximal tubular dysfunction [10] . By contrast, with myeloma-associated FS, morphological and molecular features of CSH featuring proximal tubular dysfunction (CSH/FS) have been poorly described [10] [11] [12] [13] .
We performed immunopathological and molecular study in three cases of κLC-associated CSH/FS. Vκ sequences and resulting molecular models were compared with previously reported κLCs myeloma-associated FS, in order to analyse the potential effect of mutations in aggregation and crystallization.
Materials and methods

Patients Patient 1 (GSC CSH
. A 52-year-old man was hospitalized for acute renal failure. Kidney biopsy revealed prominent interstitial plasma cell and lymphocyte infiltration without vascular or glomerular lesions. A diagnosis of drug-induced immuno-allergic tubulo-interstitial nephritis was suspected. Prednisone therapy resulted in decrease in serum creatinine level from 3.0 to 1.4 mg/dl in 3 months. Over the three following years, the patient presented recurrent episodes of acute renal failure despite steroid therapy. Three yearly kidney biopsies revealed persistent interstitial infiltration by mononuclear cells. Symptoms of FS were detected 4 years after initial admission, along with serum IgM monoclonal gammopathy (10.6 g/l, n <1.4 g/l) with κ Bence-Jones proteinuria (Table 1) . Renal function slowly worsened, with a serum creatinine level of 2.9 mg/dl after 20 years. At that time, further investigations confirmed FS with generalized aminoaciduria. All kidney biopsies were reviewed, and CSH was diagnosed. Bone marrow smears and biopsy did not show evidence of malignant lymphocytic or plasma cell infiltration but numerous PPGC. Prednisone was reintroduced for 3 years, until the patient died of sepsis after 25 years of follow-up (serum creatinine 4.3 mg/dl).
Patient 2 (MOR CSH ).
A 70-year-old man was admitted for chronic renal failure. Clinical examination was unremarkable except for spleen enlargement. Laboratory investigations showed white blood cell count 5500/μl, haemoglobin 11.1 g/dl, urea 3.5 mg/dl, serum creatinine 2.4 mg/dl, total protein 70 g/l, K 3.1 mmol/l, Ca 2.59 mmol/l, phosphate 1.09 mmol/l, uric acid 221 μmol/l and proteinuria 0.8 g/day (Table 1) . Increased fractional excretion (FE) of uric acid (46%) and phosphate (32%) with orthoglycaemic glucosuria of 0.6 g/day and normal urine amino acid excretion indicated incomplete proximal tubular dysfunction. A monoclonal IgMκ paraprotein was found in the serum and urine. Serum-free κLC level was 522 mg/l. Tests for cryoglobulins were negative. Bone marrow smears and skeletal X-rays were normal. A kidney biopsy was performed, and CSH was diagnosed. Six monthly courses of chlorambucil plus prednisone resulted in reduction of serum-free κLC levels to 388 mg/l and serum IgM level to 1.4 g/l. Two months after treatment withdrawal, the patient developed severe thrombopaenia. Serum creatinine level was 0.9 mg/dl, without glucosuria, but hypophosphataemia (0.63 mmol/l) and hypouricaemia (120 μmol/l) persisted with increased FE of 25% and 59%, respectively. Bone marrow smears revealed diffuse infiltration by CD19+CD20+ sIgMκ-positive cells suggesting progression to large B-cell lymphoma. Chemotherapy with cyclophosphamide, adriamycin, vincristin, prednisone and rituximab was initiated. The patient died of sepsis after six courses of treatment (serum creatinine 3.2 mg/dl).
Patient 3 (MAR CSH
. A 65-year-old man was referred for acute worsening of chronic renal failure. He had a past history of IgGκ monoclonal gammopathy and full-blown FS with normoglycemic glucosuria and generalized hyperaminoaciduria, discovered 13 years before. At that time, serum creatinine level was 2.8 mg/dl, and a kidney biopsy showed severe tubulointerstitial nephritis with extensive interstitial fibrosis. Upon admission, physical examination was unremarkable. Biological tests revealed: serum creatinine 6.3 mg/dl, slight microscopic haematuria and proteinuria of 2.50 g/day (Table 1 ). Potassium was 3.8 mmol/l, HCO 3 23 mmol/l, total protein 8.6 g/dl, albumin 4.8 g/dl, Ca 2.49 mmol/l and phosphate 0.8 mmol/l. Immunoelectrophoresis revealed a serum monoclonal IgGκ and κ Bence-Jones proteinuria. Serum IgG level was 2.93 g/dl (N 0.69-1.6 g/l) with decreased IgA and IgM levels. No cryoglobulin was detected. Full blood count was normal. Bone marrow smears, trephine and a second kidney biopsy led to the diagnosis of CSH. No specific treatment was introduced. Chronic renal failure worsened, and haemodialysis was started 19 months after diagnosis and 15 years after the first kidney biopsy.
Pathological studies
The remaining samples, obtained from routine laboratory investigations, were used for the study according to Helsinki recommendations. All kidney biopsy specimens were examined by light microscopy using standard methods [7] . Direct immunofluorescence (IF) and/or immunohistochemistry (IHC) studies were performed using conjugates specific for human Ig γ, μ, α HCs, κ and λLCs (Dako). Electron microscopy (EM) and/or immunoEM were performed on urinary sediment (GSC CSH ), bone marrow (GSC CSH ) and kidney biopsy (MOR CSH ) specimens, as previously described [7] . Study of cytoplasmic Ig was performed on peripheral and bone marrow mononuclear cells by direct IF [14] .
Molecular biology studies
RNA was extracted from bone marrow and prepared in triPure (Roche GmbH). The cDNAs were synthesized using superscript II reverse transcriptase (Invitrogen). To determine each Ig LC subgroup, PCR amplification was performed with cDNA as template, a 3′ primer complementary to the upstream part of the Cκ exon and 5′ primers representing consensus sequences of leader regions for each Vκ subgroup. The 3′ primer was 5′-CGGGAAGATGAAGACAGATGGTGCACC-3′, and 5′ primers were: Vκ I (5′-ATGGACATGAGGGTCCCCGCT-3′), Vκ II (5′-ATGAGGCTCCCTGCTGCTCAGCTC-3′), Vκ III (5′-ATG-GAAGCCCCAGCGCAGCTT-3′) and Vκ IV (5′-ATGGTGTGGCA-GACCCAGGTC-3′).
PCR amplification was performed using Taq DNA polymerase (Qiagen, Valencia, CA). The cDNA was amplified after denaturation for 5 min at 94°C
, followed by 35 cycles of 30 s at 94°C, 30 s at 55°C, 45 s at 72°C and a final elongation step at 72°C for 10 min. PCR products were cloned into PCRII-TOPO vector (Invitrogen, Carlsbad, CA) and sequenced. Sequences repeatedly obtained from independent PCR experiments were assigned to the proliferating clone and compared with the germline and previously studied κ LCs responsible for myeloma-associated FS. Searches for homologies were made using the Blast server at the National Center for Biotechnology Information and ImMunoGeneTics (IMGT) database.
Theoretical isoelectric points (pI) of CSH and FS κLCs were calculated using ExPASy proteomics server (http://www.expasy.ch).
Molecular modelling
Molecular modelling of Vκ/Jκ domains was made by homology to the 1LVE human κLC LEN crystal structure (Vκ IV /Jκ2 subgroup), determined by X-ray diffraction using a resolution of 1.95 Å [15] . The identity of 1LVE with the three CSH/FS LCs studied here was approximately 80%. The original X-ray structure was optimized using the AMBER force field parameterized for proteins, as implemented in the Insight II software (http://accelrys.com). Water molecules included in the original X-ray structure (1LVE) were kept during the calculation. The convergence criterion was fixed at 0.001 kcal/mol/Å for the maximum gradient. The same strategy was used to establish the 15 molecular structures, germline sequences: O8/O18, O2/O12, A27, L2 and L6; and patient sequences: of crystals, respectively). The amino acids that differed from 1LVE were replaced, and the resulting sequences were computed in order to provide 3D models.The LEN Jκ2 was used as template for germline sequences and for VAL FS+ because Jκ VAL FS+ was not available. Energy minimalizations, optimizations and superimpositions were achieved using the Insight II software. The VMD software was used to create and visualize the solvent-excluded surfaces. The different regions on Ramachandran plots of all the structures are as described by Morris et al. [16] .
Protease treatment
Bence-Jones proteins were precipitated with 50% ammonium sulphate for 1 h at +4°C and dialysed against Tris buffer after centrifugation.
Trypsin digestion was performed in 0.1 M NaCl, 50 Mm Tris buffer, pH 8.2 at 37°C with an enzyme substrate ratio of 1:50. κLCs were incubated 1, 3 and 6 h with trypsin (Gibco) and then analysed by western blot and revealed by a rabbit anti-human κLC antibody (Dako). The control monoclonal κLC BON was obtained from a patient with biopsy-proven κLC deposition disease without any proximal tubule crystalline inclusions.
Results
Pathological findings
Kidney biopsies. Kidney biopsy samples from patients GSC CSH (n = 4), MAR CSH (n = 2) and MOR CSH (n = 1) were reviewed. In all cases, light microscopy revealed interstitial infiltration by mononuclear cells, with diffuse interstitial fibrosis of variable severity. A moderate population of interstitial histiocytes contained eosinophilic crystalline inclusions with the appearance of Gaucher cells. These PPGC were numerous within peri-renal adipose tissue in all patients ( Figure 1A , G and I).
No specific glomerular lesions were observed, and mesangial cells and podocytes did not contain inclusions. Congo-red staining was negative, and no myeloma casts were seen. In all three patients, proximal tubular lesions were prominent, with focal atrophy and brush border disappearance, whereas some cells appeared turgescent and contained intra-cytoplasmic needle-shaped crystals ( Figure 1B and E-G[insert]). No staining of proximal tubular cells was initially described with anti-LC conjugates by IF. However, a strong cytoplasmic staining that predominated at the periphery of crystals was observed with antikappa LC conjugate by IHC in patients GSC CSH and MOR CSH ( Figure 1G [insert]). In patient MOR CSH , interstitial infiltrating cells and cellular casts ( Figure 1H ) stained for CD68 and κLC, while subcapsular plasmacytoid cells and histiocytes stained with the anti-κ conjugate ( Figure 1G and H) . IHC studies were not available for patient MAR CSH . By EM, needle-shaped crystals were observed in the cytoplasm of altered cells in GSC CSH urinary sediment ( Figure 2D ). In patient MOR CSH , few proximal tubular cells contained numerous electron-dense inclusions organized into 7 to 8 nm diameter amyloid-like fibrils, which were decorated solely by the anti-κ gold conjugate ( Figure 2E and F).
Bone marrow smears and biopsies. Initial bone marrow smears revealed the absence of obvious lymphocytic or plasma cell infiltration in patients GSC CSH and MOR CSH but the presence of a few PPGC with enlarged and multi-lamellar cytoplasm and a few plasmacytoid cells containing inclusions suggestive of Ig crystals ( Figure 1C and D) . By EM, bone marrow histiocytes in patient GSC CSH contained intra-cytoplasmic needle-like crystals ( Figure 2C ). In MOR CSH , IF study of cytoplasmic Ig in suspended bone marrow cells showed 10-15% μκ-positive lympho-plasma cells with intra-cytoplasmic inclusions that strongly stained for μ and κ chains. Using the same IF study, a small 5-7% population of peripheral blood lymphocytes that displayed strong cytoplasmic staining with anti-μ and anti-kappa conjugates was observed. Bone marrow from patient MAR CSH showed 30% infiltration by monotypic CD138 and κ-positive plasma cells, some containing eosinophilic inclusions. A diagnosis of multiple myeloma stage I-B was made.
Sequence analysis. Bone marrow cDNAwas PCR amplified with Vκ-specific primers, and a single sequence was repeatedly amplified: Vκ III for GSC CSH Figure 3A , Table 2 ). Deduced protein sequences were aligned with germline and previously published myelomaassociated FS κLCs ( Figure 3B ). Compared to germline, GSC CSH revealed 10 unusual residues, with five possibly modifying either hydrophobicity or charge: substitutions of polar with hydrophobic residues occurred in the first complementary determining region (CDR1; position 33), in the CDR2 (position 53) and in the third framework region (FR3) (positions 64 and 73). A charged residue at position 39 replaced a polar residue ( Figure 3B ). MOR CSH sequence exhibited only one substituted residue (Ser replaced Phe at position 85, Figure 3B ). MAR CSH LC displayed eight remarkable substitutions: three apolar residues replaced polar ones at positions 9, 12 (FR1) and 56 (FR3), one charged residue was replaced by a polar residue at position 55 and four polar residues were replaced by charged residues at positions 53, 76, 79 and 93 ( Figure 3B ). (iii) mutation in CDR3 also induced a change in the solvent-excluded surface of CHEB FS+ ; and (iv) an exposed hydrophobic region (60-63) was present in TRO FS+ κLC. Modelling of O8/O18-encoded LCs ( Figure 4C and D) showed: (i) residue 56 (Pro in MAR CSH ) was strongly exposed for MAR CSH compared to MAS FS− and DEL FS− and was rather hydrophobic, as indicated by the absence of water molecules around this residue after geometry optimization; (ii) in MAR CSH , two Ala residues (9 and 12) created an exposed hydrophobic region interacting with Ile83 (FR3) and mutated residues Val105 and Phe106 of FR4 region ( Figure 4D ). The GSC CSH LC showed exposed hy- Leader peptide exon   CSH   ATG GAA GCC CCA GCG CAG CTT CTC TTC CTC CTG CTA CTC TGG CTC CCA GAT ACC ACC GGA GAA ATT GTG TTG ACG CAG   TCT CCA GGC ACC TTG TCT TTG TCT CCA GGG GAA AGA GCC ACC CTC TCC TGC AGG GCC AGT CAG AGT GTT AGC AAC AAC   TTC TTA GCC TGG TAC CAG AAG AAA CCT GGC CAG GCT CCC AGA CTC CTC ATC TAT GGT GCA TTC AAC AGG GCC ACT GGC   ATC CCA GAC AGG TTC GGT GGC AGT GGG TCT GGG ACA GAC TTC ATT CTC ACC ATC AAT AGA CTG GAG CCT GAT GAT TTT  Jκ1  GCA GTG TAT TAC TGT CAG CAG TAT GGT AGC TCA CCT TGG ACG TTC GGC EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRA.TGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSP GSC 
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Protease treatment
In patients with CSH/FS, trypsin digestion showed the generation of resistant fragments after 6 h ( Figure 5 ). This fragment was about 12 kDa for MAR CSH and 8 kDa for MOR CSH . Two fragments were observed for GSC CSH after 3 h (8 and 12 kDa), but only one (8 kDa) was resistant after 6 h. The control BON κLC did not generate any fragment resistant to trypsin.
Discussion
Renal involvement in CSH is poorly documented. Lebeau et al. reported renal disease in six cases out of 60 reviewed [8] , often diagnosed post-mortem [17] [18] [19] [20] . Few patients with CSH and renal manifestations were further reported. As in the present cases, interstitial lesions predominated with infiltration by mononuclear cells and crystal-containing histiocytes, accompanied by interstitial fibrosis and tubular atrophy [10, 21, 22] . Because PPGC represent a minor component of infiltrates, renal involvement in CSH may be misdiagnosed as immuno-allergic interstitial nephritis as in GSC CSH . The observation of numerous PPGC in peri-renal adipose tissue should suggest the diagnosis of CSH-related nephropathy. Although little attention was paid to this finding, predilection for adipose tissue of crystal-containing mononuclear cells has been described in peri-renal connective tissue [23] subcutaneous fat [24] or in a case of immunocytoma complicated by multifocal fibrosclerosis with multiple tissue involvement [17] . Glomerular changes in CSH are inconstant, but Ig inclusions have been described in podocytes [10, 20, 23, [25] [26] [27] [28] and/or mesangial cells. In our patients, as in previously reported cases [23, 28, 29] , chronic renal failure slowly progressed, a finding reminiscent of the natural course of myelomaassociated FS. CSH-associated tubulo-interstitial lesions may coexist with other monoclonal LC-related renal disorders, including myeloma cast nephropathy [20, 28, 30] and immunoglobulinic amyloidosis (AL-type) [31] .
Proximal tubular dysfunction was a constant feature in our cases, with full-blown FS in patients GSC CSH and MAR CSH . FS was described in only seven previous cases of CSH [11] [12] [13] 22, 30, 32] , but the frequency of proximal tubular dysfunction in CSH is probably underestimated. CSH/ FS appears to be associated with characteristic proximal tubular lesions, including hypertrophy of few epithelial cells filled with electron-dense crystalline inclusions, contrasting with atrophy of the adjacent tubular cells [30] . Diagnosis of proximal tubular LC inclusions is challenging, since in the present cases, they were not detected by conventional IF but by immunohistochemistry after antigen activation through oven heating. Other techniques may be required, including IF on pronase-digested tissue [33, 34] or immunoEM [22, 35] . Pathological findings in CSH/FS are reminiscent of those in classical myeloma-associated FS, where more numerous clarified proximal tubular cells contain κLCs inclusions [36] . However, some characteristics of tubular involvement in CSH appear to be distinct. Free Ig crystals within distal tubule lumens, sometimes described in myeloma-associated FS, were neither observed in the previous nor in the present cases of CSH/FS. In myeloma-associated FS, EM commonly reveals intra-cytoplasmic hexagonal or diamond-shaped crystals, with a lattice-like structure [6, 36, 37] (Figure 2A and B) . By contrast, Ig inclusions in CSH/FS usually show needle-shaped, rectangular and rhomboid patterns, as observed in GSC CSH bone marrow histiocytes and urinary sediment [8, 10, 21, 27, 30] . A microtubular or fibrillary amyloid-like appearance of crystalline inclusions, similar to that found in patient MOR CSH , has been rarely reported in patients with LC-associated proximal tubulopathy [33, 38] . Our results suggest that differences in the ultrastructural patterns of inclusions in CSH/FS and myeloma-associated FS result from distinct structures of monoclonal κLCs.
The mechanisms of LCs crystallization remain unclear. The isoelectric point may influence patterns of tissue depo- Crystal-storing histiocytosis and Fanconi syndrome 2987 sition. For example, monoclonal κLCs in non-amyloid LC deposition disease are characterized by high pI [39] , whereas amyloidogenic LCs display lower pI [40, 41] . In the present CSH/FS cases, crystallization appeared independent of the pI as in myeloma-associated FS κLCs [5] . Previous studies showed that specific mutations are strongly involved in crystallization in myeloma-associated FS, where substitution of a polar residue by a hydrophobic residue at CDR1 ) without crystals have been extensively studied [4, 7] . When compared with SU FS− and VAL FS− LCs, only GSC CSH LCs showed mutations with hydrophobic zones exposed to solvent. No hydrophobic mutations were observed for MOR CSH but only a slight difference in the deviation angle of the residue 95 compared to SU FS− and VAL FS− . However, beyond the anomalies suggested by molecular modelling, crystallization might also involve parameters such as self-affinity or interactions between protease-resistant fragments, promoting an initial aggregation as a first step towards crystallization [43, 44] . All three CSH/FS κLCs were characterized by resistance of the V domain to trypsin digestion that might promote crystallization, as myeloma-associated FS LCs [4, 6, 7] . Proteolysisresistant fragments of 8 and 12 kDa were observed for Vκ III and Vκ I CSH/FS κLCs, respectively, but not for control LCs. The 12-kDa fragment was described for myeloma-associated FS κLCs after trypsin or cathepsin B action [4, 6, 7] . This suggests that complete proteolysis of the V domains cannot occur after endocytosis in proximal tubular cells or macrophages, leading to accumulation of the V fragment within the lysosomal compartment.
In this study, pathological characteristics of CSH/FS and myeloma-associated FS suggests different mechanisms of LC crystallization. In myeloma-associated FS, crystals predominate within monoclonal bone marrow plasma cells. Few crystals are observed within histiocytes, indicating that crystallization occurs after phagocytosis of free crystals or of dying plasma cells. In CSH/FS, plasma cells contain only few cytoplasmic LC inclusions, which are predominantly found within histiocytes and epithelial cells, suggesting that Ig crystallization occurs after endocytosis and proteolysis within the endolysosomal compartment of histiocytes and epithelial cells.
In conclusion, myeloma-associated FS and CSH/FS feature crystal formation by a limited set of monoclonal Ig, most often κLC. These disorders differ by their clinicopathological presentation and by molecular peculiarities of monoclonal κLCs that probably govern location and pattern of crystal formation. Whether aggressive treatment of the underlying B-cell clone, often incipient and diagnosed after in-depth bone marrow studies with sensitive techniques, might influence survival and renal prognosis remains to be determined.
